申联生物
(688098)
| 流通市值：39.67亿 | | | 总市值：39.67亿 |
| 流通股本：4.11亿 | | | 总股本：4.11亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 74,266,451.73 | 53,076,209.98 | 96,483,629.97 | 146,206,489.54 |
| 交易性金融资产 | 60,398,472.24 | 75,883,586.11 | 44,705,858.23 | 43,814,890.86 |
| 应收票据及应收账款 | 325,449,214.38 | 284,765,920.29 | 303,259,258.69 | 261,397,654.93 |
| 其中：应收票据 | 137,570.4 | 671,136.84 | 1,099,939.5 | - |
| 应收账款 | 325,311,643.98 | 284,094,783.45 | 302,159,319.19 | 261,397,654.93 |
| 预付款项 | 2,347,238.47 | 788,244.8 | 895,412.95 | 1,078,554.81 |
| 其他应收款合计 | 4,056,745.21 | 3,405,789.95 | 3,407,026.69 | 3,170,654.55 |
| 存货 | 80,960,935.32 | 96,460,961.3 | 93,127,951.11 | 95,102,892.07 |
| 其他流动资产 | - | 121,652.81 | 59,659.39 | 59,659.39 |
| 流动资产合计 | 547,479,057.35 | 514,502,365.24 | 541,938,797.03 | 550,830,796.15 |
| 非流动资产: | | | | |
| 长期股权投资 | 22,616,464.96 | 21,034,042.22 | 11,588,127.57 | 1,582,608.87 |
| 其他权益工具投资 | 5,500,000 | 5,500,000 | 5,000,000 | 5,000,000 |
| 固定资产 | 718,420,144.13 | 734,829,277.67 | 749,600,517.5 | 631,281,073.17 |
| 在建工程 | 92,495,163.3 | 79,688,045.44 | 58,996,253.29 | 177,870,534.68 |
| 生产性生物资产 | 307,771.93 | 357,719.97 | 233,795.46 | 312,807.95 |
| 使用权资产 | 1,902,344.01 | 2,049,039.32 | 2,313,921.75 | 1,726,628.01 |
| 无形资产 | 124,684,173.38 | 119,444,098.98 | 100,323,925.4 | 102,664,230.95 |
| 开发支出 | 13,425,036.47 | 18,499,297.61 | 36,944,445.18 | 33,184,095.1 |
| 递延所得税资产 | 12,647,846.74 | 14,823,013.03 | 13,494,919.63 | 13,259,954.26 |
| 其他非流动资产 | 20,858,879.3 | 25,947,086.1 | 40,225,641.1 | 36,405,220 |
| 非流动资产合计 | 1,012,857,824.22 | 1,022,171,620.34 | 1,018,721,546.88 | 1,003,287,152.99 |
| 资产总计 | 1,560,336,881.57 | 1,536,673,985.58 | 1,560,660,343.91 | 1,554,117,949.14 |
| 流动负债: | | | | |
| 短期借款 | 13,447,280 | 13,447,280 | 14,008,341.66 | 14,008,341.67 |
| 应付票据及应付账款 | 11,377,085.97 | 6,297,440.04 | 9,111,752.12 | 5,438,414.72 |
| 应付账款 | 11,377,085.97 | 6,297,440.04 | 9,111,752.12 | 5,438,414.72 |
| 合同负债 | 12,151,630.12 | 15,080,733.51 | 17,301,686.21 | 17,343,332.38 |
| 应付职工薪酬 | 10,062,947.89 | 7,800,946.31 | 6,586,454.57 | 15,225,900.61 |
| 应交税费 | 3,694,644.92 | 1,142,345.91 | 3,628,702.74 | 1,598,708 |
| 其他应付款合计 | 66,231,486.79 | 61,306,438.28 | 67,110,625.83 | 52,591,117.74 |
| 应付股利 | 553,005.07 | 553,005.07 | 553,005.07 | 553,005.07 |
| 一年内到期的非流动负债 | 469,827.98 | 532,035.86 | 598,918.47 | 475,512 |
| 其他流动负债 | 10,690,867.97 | 10,334,916.29 | 10,054,162.99 | 9,520,015.15 |
| 流动负债合计 | 128,125,771.64 | 115,942,136.2 | 128,400,644.59 | 116,201,342.27 |
| 非流动负债: | | | | |
| 租赁负债 | 1,255,643.12 | 1,210,436.71 | 1,438,411.22 | 1,005,937.22 |
| 递延收益 | 9,601,215.87 | 10,094,460.36 | 10,587,704.85 | 11,080,949.34 |
| 递延所得税负债 | 434,549.57 | 526,770.72 | 345,615.35 | 207,258.25 |
| 非流动负债合计 | 11,291,408.56 | 11,831,667.79 | 12,371,731.42 | 12,294,144.81 |
| 负债合计 | 139,417,180.2 | 127,773,803.99 | 140,772,376.01 | 128,495,487.08 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 410,644,000 | 410,644,000 | 410,644,000 | 410,644,000 |
| 资本公积 | 539,233,471.91 | 539,233,471.91 | 539,233,471.91 | 539,233,471.91 |
| 减:库存股 | 20,004,297.06 | 20,004,297.06 | 20,004,297.06 | 18,324,408.37 |
| 盈余公积 | 75,020,487.07 | 75,020,487.07 | 75,020,487.07 | 75,020,487.07 |
| 未分配利润 | 404,999,713.72 | 391,851,961.22 | 401,701,795.55 | 404,721,662.16 |
| 归属于母公司股东权益合计 | 1,409,893,375.64 | 1,396,745,623.14 | 1,406,595,457.47 | 1,411,295,212.77 |
| 少数股东权益 | 11,026,325.73 | 12,154,558.45 | 13,292,510.43 | 14,327,249.29 |
| 股东权益合计 | 1,420,919,701.37 | 1,408,900,181.59 | 1,419,887,967.9 | 1,425,622,462.06 |
| 负债和股东权益合计 | 1,560,336,881.57 | 1,536,673,985.58 | 1,560,660,343.91 | 1,554,117,949.14 |
| 公告日期 | 2025-10-27 | 2025-08-30 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |